publication venue for
- Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.. 144. 2021
- Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry.. 143. 2019
- Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.. 137. 2017
- Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia.. 136. 2016
- Hypogonadism in patients with sickle cell disease: central or peripheral?. 128. 2012
- Evaluation of the incidence of sensorineural hearing loss in beta-thalassemia major patients under regular chelation therapy with desferrioxamine.. 108. 2002
- Biological determinants of long-term survival in chronic myelogenous leukemia patients treated with conventional chemotherapy.. 97. 1997
- Transfer of human adenine deaminase gene into murine hematopoietic stem cells: sequential study of spleen colony-forming units from bone marrow of living mice and the requirement of the microenvironment.. 96. 1996
- Incidence and treatment of tumor lysis syndrome in patients with acute leukemia.. 91. 1994
- Marrow storage techniques: a clinical comparison of refrigeration versus cryopreservation.. 85. 1991
- Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma.. 83. 1990
- Immunophenotypic demonstration of two natural killer surface markers, H25 and H366, on fresh human leukemic cells.. 82. 1989
- Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cells.. 80. 1988
- Comparative regimens for the ex vivo chemopurification of B cell lymphoma-contaminated marrow.. 80. 1988
- Ex vivo treatment of myeloma cells by 4-hydroperoxycyclophosphamide and VP-16-213.. 80. 1988
- Acute febrile neutrophilic dermatosis (Sweet syndrome) in acute myeloid leukemia patients: a 28-year institutional experience. 2023
- It's Time to Take Clarithromycin Seriously in Multiple Myeloma.. 135. 2015
- JAK2 and MPL mutations in myeloproliferative neoplasms. 2008